Sex and thyroid hormone status in women with rheumatoid arthritis

Basit Öğe Kaydı
dc.contributor.authorCevik, R
dc.contributor.authorEm, S
dc.contributor.authorGur, A
dc.contributor.authorNas, K
dc.contributor.authorSarac, AJ
dc.contributor.authorÇolpan, L
dc.date.accessioned2024-04-24T17:11:31Z
dc.date.available2024-04-24T17:11:31Z
dc.date.issued2004
dc.departmentDicle Üniversitesien_US
dc.description.abstractThere has been considerable interest in the role of hormones in the aetiopathogenesis of rheumatoid arthritis (RA). In this study, we aimed to investigate sex and thyroid hormone conditions according to menopausal state and disease activation in RA women. Fifty-four women with RA were included in the study. Age-matched 28 women with low back pain were used as controls. Sex and thyroid hormones were evaluated in all patients, which included the measurement of estractiol (E-2), progesterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, thyroid-stimulating hormone (TSH), total (T) and free (F) triiodothyronine (T3) and (T) and (F) thyroxine (T4). The RA patients were subdivided according to their pre-menopausal and post-menopausal Status and their disease activation conditions. Mean age was 45.68 (+/-12.5) in women (aged 22-70) with RA;and 42.39 (+/-12.45) in controls (aged 22-62). There were no significant differences in sex hormones, but there were statistically significant higher levels of TT3 and TT4 in whole women with RA compared to controls. Lower concentrations of FSH were detected in active RA patients. There were statistically lower concentrations of LH and higher concentrations of TT3 and TT4 in pre-menopausal RA women, while lower concentrations of FSH were detected in post-menopausal RA women. TT3 and FT3 levels of pre-menopausal RA women were significantly higher than post-menopausal RA women. There were no significant differences for all other hormones studied. In conclusion, sex and thyroid hormones have been influenced in women with RA. Reproductive and menopausal conditions should be taken into consideration when sex and thyroid hormones studies are carried out in RA women.en_US
dc.identifier.doi10.1111/j.1368-5031.2004.00005.x
dc.identifier.endpage332en_US
dc.identifier.issn1368-5031
dc.identifier.issue4en_US
dc.identifier.pmid15161114
dc.identifier.scopus2-s2.0-2642518675
dc.identifier.scopusqualityQ1
dc.identifier.startpage327en_US
dc.identifier.urihttps://doi.org/10.1111/j.1368-5031.2004.00005.x
dc.identifier.urihttps://hdl.handle.net/11468/17572
dc.identifier.volume58en_US
dc.identifier.wosWOS:000221474300002
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherBlackwell Publishing Ltden_US
dc.relation.ispartofInternational Journal of Clinical Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRheumatoid Arthritisen_US
dc.subjectMenopauseen_US
dc.subjectSex And Thyroid Hormonesen_US
dc.titleSex and thyroid hormone status in women with rheumatoid arthritisen_US
dc.titleSex and thyroid hormone status in women with rheumatoid arthritis
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu